Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome.
about
Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaThe epigenetic basis of diffuse large B-cell lymphomaEZH2 in Bladder Cancer, a Promising Therapeutic TargetLong non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expressionMIR146A inhibits JMJD3 expression and osteogenic differentiation in human mesenchymal stem cells.Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation?Gene mutations and molecularly targeted therapies in acute myeloid leukemia.MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2Long intergenic non-coding RNA 00152 promotes tumor cell cycle progression by binding to EZH2 and repressing p15 and p21 in gastric cancer.Role of EZH2 histone methyltrasferase in melanoma progression and metastasisEZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD.Long non-coding RNA CCAT2 promotes gastric cancer proliferation and invasion by regulating the E-cadherin and LATS2.Interplay of chromatin modifications and non-coding RNAs in the heartLong intergenic non-coding RNA 00152 promotes renal cell carcinoma progression by epigenetically suppressing P16 and negatively regulates miR-205.The non-coding transcriptome as a dynamic regulator of cancer metastasisRoles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.EZH2 is overexpressed in laryngeal squamous cell carcinoma and enhances the stem-like properties of AMC-HN-8 cells.Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphomaLong noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).EZH2 inhibitors: a patent review (2014-2016).Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatmentCancer epigenetics: new therapies and new challenges.Dynamic regulation of EZH2 from HPSc to hepatocyte-like cell fate.Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/ β-catenin signaling pathway.Long non-coding RNA LOC554202 modulates chordoma cell proliferation and invasion by recruiting EZH2 and regulating miR-31 expression.Long noncoding RNA PVT1 promotes hepatocellular carcinoma progression through regulating miR-214.Developmental epigenetic programming of adult germ cell death disease: Polycomb protein EZH2-miR-101 pathway.SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
P2860
Q26752381-6130C773-83F9-4734-ABC5-7A60C62E7782Q26852288-D86E3F11-D143-47AC-B634-E9E08C3B33F6Q28082054-CE585879-87E2-42CC-9BCB-0AC9ABBBF9BBQ33709689-ED8DE6DC-C587-4B2A-B50F-FFDC55717BB7Q33852976-F3DF5ED5-640D-421E-8E13-47C309B16938Q34584549-13E9120A-AC3D-474C-A01C-6D15E82D91ECQ34647741-B4F8AD4B-F377-456E-9F7E-80958E3CA783Q35922940-2685C27E-105A-4963-90D9-82E3D2118EB2Q35959917-FA9E25D2-DBC0-4B67-B7E8-8845A17EF9C1Q36544911-D74FAC86-86CD-45A4-AC97-07B9E82BC407Q36962787-BCC7F3EB-6AB7-4934-84EC-7A9AD7E17720Q37187733-018227B5-085F-465C-8D2E-293DD848080BQ37420964-3E533E92-A8CA-4F61-BD9E-99DDD2616937Q37447932-C065998E-ED38-48CD-8263-5135B02F51E8Q37591520-73E2A91E-8F7D-4A44-B3E8-C1F3E5CD69F8Q37680005-08DC4F9F-8885-488C-A46E-5FEB84458B5AQ37705696-9FF85988-D3E7-4A57-854C-6108AD10388BQ38185265-1D97E614-E475-4E9E-9BB4-A05A00BAA1ABQ38756492-541C5707-F074-4C7A-86CF-525DB06B22CCQ38823157-35D32E2E-931C-4DC7-BB4D-35762E91627AQ38830980-5C106FBB-4E6D-4F19-A9EB-14A17DF9570FQ38844652-7A1EE86F-FEA5-4324-A22D-AF881ADA87C1Q38918665-A34373A2-C6F1-44B3-A3BE-310801B8770BQ39312009-5D8D6AC1-AA81-45D1-B7FC-376500F6B169Q39340502-59403138-684F-4AFB-9799-DB740A11B577Q40014635-E9E2328F-DD5A-40CD-A4B2-30B0E36AE7AAQ43226742-B865ADF9-BC08-404A-8E97-96BE2EF98954Q47094482-BB5EE2F3-0B0B-405A-92B9-E48D77D40404Q47128929-96807742-C879-4319-ACA5-B304DF2BC933Q47722380-B76D9D47-058D-481B-A282-C69209AF34A5Q47964172-A318874B-0EA0-47E2-A4AA-771CB2098A99Q50479840-B2BD3353-DFE7-4567-9393-B4E6EE122909Q52593392-A09B2BB7-09D8-4BA1-80FA-495455F21FB8Q54983022-61BB9D8B-A8B1-4A30-9B25-1ECFBD2FB641
P2860
Non-coding RNAs and EZH2 interactions in cancer: long and short tales from the transcriptome.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Non-coding RNAs and EZH2 inter ...... tales from the transcriptome.
@en
type
label
Non-coding RNAs and EZH2 inter ...... tales from the transcriptome.
@en
prefLabel
Non-coding RNAs and EZH2 inter ...... tales from the transcriptome.
@en
P2093
P2860
P356
P1476
Non-coding RNAs and EZH2 inter ...... t tales from the transcriptome
@en
P2093
Evangelos Voulgaris
George Vartholomatos
Leonidas Benetatos
P2860
P304
P356
10.1002/IJC.27859
P577
2012-10-17T00:00:00Z